Trials / Not Yet Recruiting
Not Yet RecruitingNCT07229716
Study on the Drug Interactions of HRS-9813, Pirfenidone and Nintedanib in Healthy Subjects
- Status
- Not Yet Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Guangdong Hengrui Pharmaceutical Co., Ltd · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This study aims to evaluate the interaction of oral HRS-9813 capsules with pirfenidone and nintedanib on the pharmacokinetics of healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HRS-9813 Capsule | HRS-9813 capsule, specified dose on specified days. |
| DRUG | Nintedanib Soft Capsules | Nintedanib soft capsules, specified dose on specified days. |
| DRUG | Pirfenidone Tablets | Pirfenidone tablets, specified dose on specified days. |
Timeline
- Start date
- 2025-11-01
- Primary completion
- 2026-04-01
- Completion
- 2026-04-01
- First posted
- 2025-11-17
- Last updated
- 2025-11-17
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07229716. Inclusion in this directory is not an endorsement.